The findings could enable earlier detection and treatment for people affected by the serious eye condition. A research team ...

A new scientific discovery at the University of Missouri could lead to the identification of a biomarker for both earlier detection and treatment of a devastating eye disease. The disease, glaucoma, ...

Two sustained-release procedural pharmaceuticals or drug-delivery options are available in the US: the bimatoprost ...

Enhanced monofocal IOLs may improve intermediate vision and preserve visual function in glaucoma patients. The study showed significant improvements in BCVA, RNFLT, and IOP for both enhanced and ...

AND JESS, YOU SAY THIS COULD BE A GAME CHANGER. YOU KNOW, IT REALLY CAN. ABOUT 3 MILLION AMERICANS HAVE GLAUCOMA AND THIS NEW TREATMENT IS BASICALLY AN IMPLANTABLE DRUG FOR THE EYE. AND DOCTORS SAY IT ...

Iantrek launched AlloFlo Uveo, a bio-interventional surgical treatment that targets the uveoscleral pathway in patients with glaucoma, according to a press release. “Over the past 15 years, glaucoma ...

Open-angle glaucoma represents one of the most prevalent causes of irreversible sight loss globally. The principal aim of treatment is to lower intraocular pressure (IOP) to slow the progression of ...

Glaucoma is a devastating eye disease that currently affects more than 3 million Americans. By the year 2050, data shows the number of cases is projected to surge to more than 6 million cases. This is ...

Proactive strategies in glaucoma care, including minimally invasive glaucoma surgery (MIGS) and physician decision-making, ...